J
Jaap W. Deckers
Researcher at Erasmus University Rotterdam
Publications - 273
Citations - 39450
Jaap W. Deckers is an academic researcher from Erasmus University Rotterdam. The author has contributed to research in topics: Myocardial infarction & Heart failure. The author has an hindex of 68, co-authored 268 publications receiving 37766 citations. Previous affiliations of Jaap W. Deckers include European Society of Cardiology & Hannover Medical School.
Papers
More filters
Journal ArticleDOI
Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study
Lies Lahousse,Maartje N. Niemeijer,Marten E. van den Berg,Peter R. Rijnbeek,Guy Joos,Albert Hofman,Oscar H. Franco,Jaap W. Deckers,Mark Eijgelsheim,Bruno H. Stricker,Guy Brusselle +10 more
TL;DR: The Rotterdam study found that chronic obstructive pulmonary disease is associated with an increased risk for SCD, and the risk especially increases in persons with frequent exacerbations 5 years after the diagnosis of COPD.
Journal ArticleDOI
Smoking behaviour in European patients with established coronary heart disease
Wilma J.M. Scholte op Reimer,Esther A.M. de Swart,Dirk De Bacquer,Kalevi Pyörälä,Ulrich Keil,Jan Heidrich,Jaap W. Deckers,Kornelia Kotseva,David A. Wood,Eric Boersma +9 more
TL;DR: The prevalence of smoking in European patients with established coronary disease is too high: one out of each five patients smokes, despite a personal advice to stop, and there is a need for the development of effective smoking cessation programmes.
Journal ArticleDOI
Hypofibrinolysis is a risk factor for arterial thrombosis at young age
Ana H. C. Guimaraes,Emile L. E. de Bruijne,Ton Lisman,Diederik W.J. Dippel,Jaap W. Deckers,Don Poldermans,Dingeman C. Rijken,Frank W.G. Leebeek +7 more
TL;DR: A low plasma fibrinolytic potential, found in 10% of the population, increases the relative risk of arterial thrombosis twofold, which points to an important contribution of hypofibrinoslysis to the burden of arterIAL thromBosis.
Journal ArticleDOI
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study.
Kenneth W. Mahaffey,Robert A. Harrington,Martijn Akkerhuis,Neal S. Kleiman,Lisa G. Berdan,Brian S. Crenshaw,Barbara E. Tardiff,Christopher B. Granger,Ingrid DeJong,Manju Bhapkar,Petr Widimsky,Ramón Corbalon,Kerry L. Lee,Jaap W. Deckers,Maarten L. Simoons,Eric J. Topol,Robert M. Califf +16 more
TL;DR: CEC adjudication provides a standard, systematic, independent, and unbiased assessment of end-points, particularly for trials that span geographic regions and clinical practice settings, as well as design future trials and interpret event rates between trials.
Journal ArticleDOI
Declining incidence of sudden cardiac death from 1990–2010 in a general middle-aged and elderly population: The Rotterdam Study
Maartje N. Niemeijer,Marten E. van den Berg,Maarten J.G. Leening,Albert Hofman,Oscar H. Franco,Jaap W. Deckers,Jan Heeringa,Peter R. Rijnbeek,Bruno H. Stricker,Mark Eijgelsheim +9 more
TL;DR: The incidence of SCD decreased from 1990-2010, a period during which the diagnosis and treatment of heart disease greatly improved, and is found to be higher in men than in women.